Cross-Reactive Memory and the Eradication of Smallpox

From Ottoman Variolation and Jenner's Cowpox Trial to Ring Vaccination

Long before the germ theory of disease or the discovery of lymphocytes, observers across Asia and the eastern Mediterranean recognized that surviving smallpox conferred lifelong resistance to future outbreaks. Caused by Variola major, a brick-shaped double-stranded DNA orthopoxvirus that killed roughly 30 percent of its victims and left survivors blinded or deeply scarred, smallpox was an inescapable tax on human childhood. In Constantinople in 1717, Lady Mary Wortley Montagu—whose brother had died of smallpox and whose own face bore its pockmarks—watched Ottoman women perform variolation by scratching fluid from a mild smallpox pustule into the skin of healthy children. She had her son inoculated in Constantinople. During the London epidemic of 1721, she arranged the public variolation of her young daughter alongside royal trials on six condemned Newgate Prison inmates. Variolation induced a genuine, localized case of Variola major whose case fatality rate of 1 to 2 percent was less than one-tenth that of natural inhalation. Inoculated patients nonetheless remained contagious and occasionally ignited fresh urban epidemics.

A safer biological boundary existed across rural dairy farms in southwestern England. There, milkmaids who contracted cowpox vesicles on their fingers from infected udders remained refractory to both natural smallpox and variolation. In May 1796 in Berkeley, Gloucestershire, country physician Edward Jenner harvested lymph from a cowpox lesion on the hand of dairymaid Sarah Nelmes and incised it into two superficial cuts on the arm of a local boy named James Phipps. Phipps developed a solitary vesicle at the inoculation site, experienced a brief axillary ache on the seventh day, and recovered completely. Six weeks later, on July 1, 1796, Jenner performed a direct variolation challenge by inoculating Phipps in both arms with infectious pus taken straight from a fresh smallpox pustule. No systemic disease or secondary eruption followed.

The molecular basis of Jenner's cross-protection lies in the evolutionary conservation of the Orthopoxvirus genus. Variola major, cowpox virus, and the Vaccinia virus that eventually replaced cowpox in nineteenth-century vaccine stocks share a nearly 200-kilobase double-stranded DNA genome encoding over two hundred proteins. Crucially, the outer viral envelopes of both intracellular mature virions and extracellular enveloped virions display homologous structural glycoproteins—including A27L, L1R, B5R, and A33R—whose three-dimensional surface epitopes are nearly identical across the genus. When orthopoxvirus antigens from Sarah Nelmes replicated locally in the dermal cells of Phipps's arm, dendritic cells carried those conserved viral proteins to the draining axillary lymph nodes. Naive B cells and $\text{CD4}^+$ and $\text{CD8}^+$ T cells whose receptors bound those shared epitopes underwent clonal expansion and differentiated into circulating memory populations. When live variola entered the dermis six weeks later, cross-reactive neutralizing antibodies and cytotoxic T cells cleared the virions before primary viremia could seed the spleen and skin.

Preserving a live virus across oceanic distances before refrigeration required maintaining an unbroken biological replication chain. Because dried vaccine lymph on silk threads lost potency in tropical heat, Spanish royal physician Francisco Javier de Balmis sailed from A Coruña aboard the corvette María Pita in November 1803 with twenty-two foundling boys who had never been exposed to poxviruses. Every nine to ten days across the Atlantic voyage to Puerto Rico, Cuba, and Mexico—and subsequently across the Pacific to Manila and Macao—Balmis transferred fluid from the maturing vesicular lesion of one pair of boys into the arms of the next pair. This living relay delivered viable orthopoxvirus across three continents.

Even with freeze-dried vaccine stocks in the mid-twentieth century, smallpox still killed two million people annually until two operational innovations closed the epidemiological circuit. In 1965, Wyeth microbiologist Benjamin Rubin ground off the tip of a steel sewing-machine needle to create a bifurcated two-pronged fork. It held $0.0025\text{ mL}$ of reconstituted vaccine by capillary tension—one-fourth of a conventional syringe dose—and deposited it into the epidermal basal layer via fifteen rapid perpendicular punctures. Starting in 1966 under World Health Organization director D. A. Henderson, epidemiologists William Foege and Karel Raška replaced slow mass-vaccination campaigns with surveillance and ring containment. Because Variola major had no animal reservoir, caused an unmistakable rash, and spread with a basic reproduction number near five, rapid ring vaccination of household contacts and village networks starved the virus of susceptible hosts. In October 1977 in Merca, Somalia, hospital cook Ali Maow Maalin recovered from the final naturally transmitted case of Variola minor, extinguishing a pathogen that had haunted human civilization for three millennia.